Cargando…
Antibodies against Phosphorylcholine—Implications for Chronic Inflammatory Diseases
Atherosclerosis and its main consequence, cardiovascular disease (CVD) are nowadays regarded as chronic inflammatory disease conditions, and CVD is the main cause of death in the world. Other examples of chronic inflammation are rheumatic and other autoimmune conditions, but also diabetes, obesity,...
Autor principal: | Frostegård, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301491/ https://www.ncbi.nlm.nih.gov/pubmed/37367878 http://dx.doi.org/10.3390/metabo13060720 |
Ejemplares similares
-
Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development
por: Frostegård, Anna G., et al.
Publicado: (2014) -
IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases
por: Thiagarajan, Divya, et al.
Publicado: (2020) -
IgM-Antibodies against Phosphorylcholine in Mothers and Normal or Low Birth Weight Term Newborn Infants
por: Frostegård, Anna G., et al.
Publicado: (2014) -
Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects
por: Jujić, Amra, et al.
Publicado: (2021) -
Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions
por: Samal, Shailesh Kumar, et al.
Publicado: (2022)